多发肺结节主病灶良恶性判断的多因素分析
Multivariate Analysis of the Judgment of Benign and Malignant Main Lesions of Multiple Pulmonary Nodules
DOI: 10.12677/acm.2025.1582273, PDF,   
作者: 王蒙蒙:西安医学院第一附属医院心胸外科,陕西 西安;彭伊梦:永寿县常宁中心卫生院全科,陕西 咸阳;杨 琳:西安医学院第一附属医院重症医学科,陕西 西安;程梓荷, 王胜昱:西安医学院第一附属医院呼吸与危重症医学科,陕西 西安
关键词: 多发肺结节主病灶影像学特征临床特点病理特点危险因素预测模型Main Lesions of Multiple Pulmonary Nodules Imaging Features Clinical Characteristics Pathological Characteristics Risk Factors Prediction Model
摘要: 目的:分析多发肺结节主病灶6 mm ≤ 直径 ≤ 20 mm患者的临床资料、影像学特征及病理特点,探讨影响其良恶性的独立危险因素并建立预测模型,帮助临床医师早期识别多发肺结节患者主病灶的良恶性,尽可能及早并准确地作出诊断和治疗。研究方法:回顾性收集西安医学院第一附属医院心胸外科2021年1月至2023年9月期间经手术治疗且病理明确的多发肺结节主病灶6 mm ≤ 直径 ≤ 20 mm患者的临床资料(年龄、性别、吸烟史、肿瘤个人或家族史)、影像学特征(大小、结节密度、生长位置、影像特征)及病理资料,根据病理结果将患者分为良性组和恶性组,通过单因素、多因素分析筛选出影响多发肺结节主病灶6 mm ≤ 直径 ≤ 20 mm良恶性的独立危险因素,并建立预测模型分析其预测效能。结果:本研究共纳入患者87例,其中良性组27人,恶性组60人,女性39例(44.8%),男性48例(55.2%),单因素分析结果表明,年龄、吸烟史、家族史、临床症状、CT值、结节位置、结节性质、结节数量、结节边界、毛刺征、分叶征、血管纠集征、支气管截断征、胸膜凹陷征、钙化均为影响主病灶良恶性的因素(P < 0.05),多因素Logistic回归分析表明,年龄(OR = 1.086, P = 0.042, 95%CI: 1.003~1.176)、亚实性结节(OR = 7.307, P = 0.046, 95%CI: 1.032~51.719)、毛刺征(OR = 5.860, P = 0.048, 95%CI: 1.019~33.685)为影响主病灶良恶性的独立危险因素,进一步建立预测模型表明其对主病灶恶性组的预测效能(AUC: 0.885, P = 0.000, 95%CI: 0.795~0.978,灵敏度:77.8%,特异度:93.3%)优于年龄(AUC: 0.644, P = 0.032, 95%CI: 0.518~0.771,灵敏度:77.8%,特异度:51.7%)、毛刺征(AUC: 0.529, P = 0.070, 95%CI: 0.396~0.661,灵敏度:40.7%,特异度:65.0%)、亚实性结节(AUC: 0.826, P = 0.000, 95%CI: 0.733~0.919,灵敏度:85.2%,特异度:78.3%)等指标,预测效能更好。结论:年龄、结节性质、毛刺征与主病灶良恶性密切关系,年龄越大、亚实性结节、有毛刺征的主病灶肺结节恶性的可能性更大,分别为良性肺结节的1.086、7.037、5.860倍。
Abstract: Objective: The clinical data, imaging characteristics and pathological characteristics of patients with the main lesions of multiple pulmonary nodules with 6 mm ≤ diameter ≤ 20 mm were analyzed, the independent risk factors affecting the benign and malignant lesions were explored and the prediction model was established to help clinicians identify the benign and malignant main lesions of patients with multiple pulmonary nodules early, and make diagnosis and treatment as early and accurate as possible. Study Method: A retrospective review was conducted of patients with the main lesions of multiple pulmonary nodules with 6 mm ≤ diameter ≤ 20 mm who underwent treatment and had a confirmed pathological diagnosis at the Department of Cardiothoracic Surgery of The First Affiliated Hospital of Xi’an Medical College from January 2021 to September 2023, and their clinical data (age, gender, smoking history, personal or family history of tumors), imaging characteristics (size, nodule density, growth location, imaging signs) and pathological data were included. According to the pathological results, patients were divided into benign and malignant groups. Univariate and multivariate analyses were conducted to identify independent risk factors affecting the benign and malignant nature of the main lesions of multiple pulmonary nodules with 6 mm ≤ diameter ≤ 20 mm, and a predictive model was established to analyze their predictive efficacy. Results: A total of 87 patients were included in this study, including 27 in the benign group and 60 in the malignant group. There were 39 females (44.8%) and 48 males (55.2%). The results of univariate analysis showed that age, smoking history, family history, clinical symptoms, CT value, nodule location, nodule nature, nodule number, nodule boundary, burr, leaf segmentation, vascular collection, bronchial resection, pleural depression, and calcification were all factors affecting the benign and malignant nature of the main lesions (P < 0.05). Multivariate Logistic regression analysis indicated that age (OR = 1.086, P = 0.042, 95%CI:1.003~1.176), subsolid nodules (OR = 7.307, P = 0.046, 95%CI: 1.032~51.719), and burr sign (OR = 5.860, P = 0.048, 95%CI: 1.019~33.685) were identified as independent risk factors affecting the benign and malignant nature of the major lesions. Further establishment of prediction model showed its predictive efficacy in the malignant group of the major lesions (AUC: 0.885, P = 0.000, 95%CI: 0.795~0.978, Sensitivity: 77.8%, Specificity: 93.3%) was better than age (AUC: 0.644, P = 0.032, 95%CI: 0.518~0.771, Sensitivity: 77.8%, Specificity: 51.7%), burr sign (AUC: 0.529, P = 0.070, 95%CI: 0.396~0.661, Sensitivity: 40.7%, Specific degree: 65.0%), and subsolid nodules (AUC: 0.826, P = 0.000, 95%CI: 0.733~0.919, Sensitivity: 85.2%, Specific degree: 78.3%), showing better predictive efficacy. Conclusion: Age, nodule nature, and burr signs are closely related to the benign or malignant nature of major lesions. Older age, subsolid nodule, and burr signs are more likely to be malignant in pulmonary nodules of major lesions, which are 1.086,7.037 and 5.860 times that of benign pulmonary nodules, respectively.
文章引用:王蒙蒙, 彭伊梦, 杨琳, 程梓荷, 王胜昱. 多发肺结节主病灶良恶性判断的多因素分析[J]. 临床医学进展, 2025, 15(8): 604-614. https://doi.org/10.12677/acm.2025.1582273

参考文献

[1] Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E. and Forman, D. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90. [Google Scholar] [CrossRef] [PubMed]
[2] Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
[3] Barton, H., Shatti, D., Jones, C.A., Sakthithasan, M. and Loughborough, W.W. (2018) Review of Radiological Screening Programmes for Breast, Lung and Pancreatic Malignancy. Quantitative Imaging in Medicine and Surgery, 8, 525-534. [Google Scholar] [CrossRef] [PubMed]
[4] Yip, R., Henschke, C.I., Yankelevitz, D.F. and Smith, J.P. (2014) CT Screening for Lung Cancer: Alternative Definitions of Positive Test Result Based on the National Lung Screening Trial and International Early Lung Cancer Action Program Databases. Radiology, 273, 591-596. [Google Scholar] [CrossRef] [PubMed]
[5] de Koning, H.J., van der Aalst, C.M., de Jong, P.A., Scholten, E.T., Nackaerts, K., Heuvelmans, M.A., et al. (2020) Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. New England Journal of Medicine, 382, 503-513. [Google Scholar] [CrossRef] [PubMed]
[6] Kuo, E., Bharat, A., Bontumasi, N., Sanchez, C., Zoole, J.B., Patterson, G.A., et al. (2012) Impact of Video-Assisted Thoracoscopic Surgery on Benign Resections for Solitary Pulmonary Nodules. The Annals of Thoracic Surgery, 93, 266-273. [Google Scholar] [CrossRef] [PubMed]
[7] Kozower, B.D., Meyers, B.F., Reed, C.E., Jones, D.R., Decker, P.A. and Putnam, J.B. (2008) Does Positron Emission Tomography Prevent Nontherapeutic Pulmonary Resections for Clinical Stage IA Lung Cancer? The Annals of Thoracic Surgery, 85, 1166-1170. [Google Scholar] [CrossRef] [PubMed]
[8] Deppen, S., Putnam, J.B., Andrade, G., Speroff, T., Nesbitt, J.C., Lambright, E.S., et al. (2011) Accuracy of FDG-PET to Diagnose Lung Cancer in a Region of Endemic Granulomatous Disease. The Annals of Thoracic Surgery, 92, 428-433. [Google Scholar] [CrossRef] [PubMed]
[9] Gao, W., Wen, C.P., Wu, A. and Welch, H.G. (2022) Association of Computed Tomographic Screening Promotion with Lung Cancer Overdiagnosis among Asian Women. JAMA Internal Medicine, 182, 283-290. [Google Scholar] [CrossRef] [PubMed]
[10] 崔宁心, 叶霖, 孙加源. 重视多发肺结节的适度诊疗[J]. 中华预防医学杂志, 2023, 57(8): 1181-1185.
[11] Li, M., Wan, Y., Zhang, L., et al. (2019) Synchronous Multiple Lung Cancers Presenting as Multifocal Pure Ground Glass Nodules: Are Whole-Body Positron Emission Tomography/Computed Tomography and Brain Enhanced Magnetic Resonance Imaging Necessary? Translational Lung Cancer Research, 8, 649-657.
[12] Gould, M.K., Donington, J., Lynch, W.R., Mazzone, P.J., Midthun, D.E., Naidich, D.P., et al. (2013) Evaluation of Individuals with Pulmonary Nodules: When Is It Lung Cancer? Diagnosis and Management of Lung Cancer, 3rd Ed.: American College of Chest Physicians Evidence Based Clinical Practice Guidelines. Chest, 143, e93S-e120S. [Google Scholar] [CrossRef] [PubMed]
[13] Bai, C., Choi, C., Chu, C.M., Anantham, D., Chung-man Ho, J., Khan, A.Z., et al. (2016) Evaluation of Pulmonary Nodules: Clinical Practice Consensus Guidelines for Asia. Chest, 150, 877-893. [Google Scholar] [CrossRef] [PubMed]
[14] 中华医学会肿瘤学分会, 中华医学会杂志社, 中华医学会. 肺癌临床诊疗指南(2022版) [J]. 中华医学杂志, 2022, 102(23): 1706 1740.
[15] 中华医学会呼吸病学分会肺癌学组, 中国肺癌防治联盟专家组. 肺结节诊治中国专家共识(2018年版) [J]. 中华结核和呼吸杂志, 2018, 41(10): 763-771.
[16] 胡晓兰, 周爱玲, 粟红霞, 等. 基于病理结局的肺结节良恶性率影响因素分析及全程管理策略优化[J]. 华西医学, 2024, 39(4): 517-520.
[17] Zhao, Y., Wang, Z., Liu, X., Chen, Q., Li, C., Zhao, H., et al. (2022) Pulmonary Nodule Detection Based on Multiscale Feature Fusion. Computational and Mathematical Methods in Medicine, 2022, Article ID: 8903037. [Google Scholar] [CrossRef] [PubMed]
[18] Khodayari Moez, E., Warkentin, M.T., Brhane, Y., Lam, S., Field, J.K., Liu, G., et al. (2023) Circulating Proteome for Pulmonary Nodule Malignancy. JNCI: Journal of the National Cancer Institute, 115, 1060-1070. [Google Scholar] [CrossRef] [PubMed]
[19] 苏雷, 张毅, 高艳, 等. 281例老年肺结节患者外科诊疗的单中心回顾性研究[J]. 中国胸心血管外科临床杂志, 2025, 32(1): 94-99.
[20] 魏欢欢, 陈英剑, 胡成进. 血清miRNAs和低剂量CT鉴别肺结节性质效果的研究[J]. 中华肿瘤防治杂志, 2024, 31(9): 543-548.